Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zhanchun Pan"'
Autor:
Meidan Liu, Yayuan Zheng, Zuguang Chen, Yumiao Qiu, Zhanchun Pan, Zitao Cai, Yapeng Shi, Junfen Cheng, Weimin Yao
Publikováno v:
Tumor Biology, Vol 39 (2017)
To evaluate the association between severe pulmonary embolism events and bevacizumab, we conducted the first meta-analysis evaluating the incidence and risk of pulmonary embolism associated with bevacizumab-based therapy. We searched PubMed, EMBASE,
Externí odkaz:
https://doaj.org/article/9f165c31369942e5bd43d0cbbbf2f720
Autor:
Huayu Ling, Zhanchun Pan, Dehui Feng, Guiqing Wu, Chunyu Lin, Weimin Yao, Baoan Zou, Ziying Lin, Yahong Wang, Gang Liu, Ting Chen, Changmei Huangfu, Lawei Yang
Publikováno v:
The FASEB Journal. 34:13461-13473
The DNA repair enzyme 8-oxoguanine DNA glycosylase-1 (OGG1) is involved in early embryonic development, as well as in multiple conditions, including cardiac fibrosis, diabetes, and neurodegenerative diseases. But, function of OGG1 in pulmonary fibros
Publikováno v:
Nuclear Technology and Radiation Protection, Vol 32, Iss 1, Pp 44-51 (2017)
In order to ensure the health and safety of female astronauts in space, the risks of space radiation should be evaluated, and effective methods for protecting against space radiation should be investigated. In this paper, a dose calculation model is
Autor:
Gang Liu, Lawei Yang, Baoan Zou, Dehui Feng, Shenglan Gao, Zhanchun Pan, Ziying Lin, Yahong Wang, Changmei Huangfu
Publikováno v:
Inflammation research : official journal of the European Histamine Research Society ... [et al.]. 67(11-12)
Tetraspanin family plays an important role in the pathogenesis of cancer, but its role in lung fibrosis is unknown. To determine whether tetraspanin 1 (TSPAN1), a member of the family, may be involved in the pathogenesis of pulmonary fibrosis. TNFα
Autor:
Weimin Yao, Jun-fen Cheng, Yumiao Qiu, Yapeng Shi, Zitao Cai, Yayuan Zheng, Meidan Liu, Zhanchun Pan, Zu-guang Chen
Publikováno v:
Tumor Biology, Vol 39 (2017)
To evaluate the association between severe pulmonary embolism events and bevacizumab, we conducted the first meta-analysis evaluating the incidence and risk of pulmonary embolism associated with bevacizumab-based therapy. We searched PubMed, EMBASE,